DE Shaw Research in license agreement with Eli Lilly and Company
Lilly will make an initial payment of $60 million to DESRES, with potential development and commercial milestone payments of up to $475 million, as well as royalties on worldwide sales
DE Shaw Research | 15/06/2022 | By Sudeep Soparkar | 1111
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy